Welcome to our dedicated page for McKesson Corporation news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson Corporation stock.
McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.
McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.
Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.
McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.
Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.
For more details on McKesson Corporation, visit www.mckesson.com.
McKesson Medical-Surgical Government Solutions LLC, based in Richmond, Va., has been awarded a five-year contract by the U.S. Department of Veterans Affairs for Federal Supply Schedule 65 II A. This contract allows greater access to McKesson’s medical supplies, including respiratory accessories and surgical instruments. According to Deborah Haywood, VP of Government Solutions, this milestone enhances McKesson’s ability to positively impact patient outcomes and create cost efficiencies in healthcare. The inclusion on the FSS facilitates expansion in providing high-quality medical supplies to federal customers, especially for veterans and the military community.
McKesson Corporation (NYSE: MCK) has announced its financial results for the third quarter of fiscal 2023. The detailed results are accessible on McKesson's Investor Relations website. A live webcast to discuss these results is scheduled for February 1st at 4:30 PM ET. McKesson is recognized as a leader in healthcare services, focusing on enhancing health outcomes through partnerships with various stakeholders, including biopharma companies and care providers. For additional insights about the company's impact in healthcare, visit McKesson.com.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on April 3, 2023, to stockholders of record as of March 1, 2023. McKesson is a leader in diversified healthcare services, committed to enhancing health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
McKesson Corporation (NYSE: MCK) will announce its third-quarter fiscal 2023 financial results on February 1, 2023, after market close. Investors can join a live webcast at 4:30 PM Eastern Time to discuss the results. The webcast will be accessible through McKesson's Investor Relations website, where the earnings release and financial documents will also be available. McKesson is a leader in healthcare services, partnering with various stakeholders to enhance healthcare access and affordability.
McKesson Corporation (NYSE: MCK) has announced its fiscal 2023 second-quarter financial results, which are available on their Investor Relations website. A live webcast for investors will be held on November 1 at 4:30 PM ET to discuss these results. McKesson, a leader in healthcare services, is committed to enhancing health outcomes for patients by collaborating with various healthcare stakeholders. For more information on McKesson's financials and upcoming events, please visit their Investor Relations site.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share. This dividend is set to be paid on January 3, 2023, to stockholders of record as of December 1, 2022. McKesson, a leader in healthcare services, aims to improve health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
McKesson Corporation (NYSE: MCK) announced an extension of its partnership with CVS Health to distribute pharmaceuticals through June 2027. This partnership, which has lasted over 20 years, aims to improve health outcomes for patients. Additionally, McKesson will release its second-quarter fiscal 2023 earnings results on November 1, 2022, with a conference call scheduled at 4:30 PM Eastern Time. The live webcast will be accessible through McKesson's Investor Relations website.
McKesson Corporation (NYSE:MCK) has announced the acquisition of Rx Savings Solutions for up to
McKesson Corporation (NYSE:MCK) has announced the appointment of LeAnn B. Smith as the new executive vice president and chief human resources officer (CHRO), effective December 1, 2022. She will succeed Tracy L. Faber, who is retiring after 11 years. Smith, who joined McKesson in 2021, will oversee all human resources functions, focusing on talent management, diversity, and organizational change. CEO Brian Tyler expressed confidence in Smith's capabilities, highlighting her extensive experience, including a previous role at Walmart.
McKesson Corporation (NYSE: MCK) announced its fiscal 2023 first-quarter financial results, now available on its Investor Relations website. The company will host a live webcast today, August 3, at 4:30 PM ET to discuss these results. McKesson continues to lead in healthcare services, collaborating with various sectors to enhance care accessibility and affordability. The press release indicates a commitment to delivering insights and services that improve health outcomes across the healthcare spectrum.
FAQ
What is the current stock price of McKesson Corporation (MCK)?
What is the market cap of McKesson Corporation (MCK)?
What services does McKesson Corporation provide?
Where does McKesson Corporation operate?
Who are McKesson's primary clients?
What makes McKesson a leading pharmaceutical wholesaler?
How does McKesson help improve healthcare delivery?
What are some recent achievements of McKesson Corporation?
Can individuals buy products directly from McKesson?
How does McKesson contribute to the healthcare industry?
What is the significance of McKesson's partnerships?
Where can I find more information about McKesson Corporation?
